Barr Seasonale Clears FDA: Labeling Includes Breakthrough Bleeding Warning
Labeling for Barr's oral contraceptive Seasonale advises prescribers to weigh the convenience of fewer planned menses against the inconvenience of increased breakthrough bleeding associated with the drug
You may also be interested in...
Barr believes "behind-the-counter" access for the Plan B emergency contraceptive may be a more significant opportunity for the product than over-the-counter access
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011